Highnoon Laboratories Approves 15% Interim Bonus Issue for Shareholders

Karachi, In a recent board meeting held via video-link on June 9, 2023, Highnoon Laboratories Limited announced the approval of an interim bonus issue for its shareholders. The resolution passed by the Board of Directors states that a bonus issue of 15% will be granted, entitling shareholders to receive 15 additional shares for every 100 shares held.

To determine the entitlement of shareholders, the company has decided to close the share transfer books from June 20th to June 22nd, 2023, inclusive. Any transfers received by the Share Registrar, Corplink (Private) Limited, until June 19th, 2023, will be considered in time for the purpose of crediting the bonus shares.

The Board further authorized the Company Secretary to oversee all necessary formalities associated with the issuance and allotment of the bonus shares. This move highlights Highnoon Laboratories’ commitment to rewarding its shareholders and strengthening their investment in the company.

Investors and shareholders can anticipate the increased value and benefits resulting from this bonus issue, as Highnoon Laboratories continues to thrive in the pharmaceutical industry.